Millions of People Will Soon Be Blindsided. Will You Be One of Them?

On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X.

Tue, April 20 at 7:00PM ET

Housing Shepherds Stocks Higher — Tuesday’s IP Market Recap

InvestorPlace Market RecapInvestors coming back from the Memorial Day holiday weekend were greeted by a raft of solid domestic news on Tuesday, and the market never looked back from its jump at the opening bell.

S&P/Case-Shiller got the momentum started with a report that housing prices rose a better-than-expected 10.9% in March, the best year-over-year gain in seven years. We also learned that the Consumer Confidence Index rose to a five-year high.

The net result was broad gains, with the Nasdaq leading the way by improving 0.86% to close at 3488.89. All but four of the Dow Jones Industrial Average components finished in the black, and the index gained 0.67% to close at a record 15409.39. Lastly, the S&P 500 ticked up 0.63% to 1660.06.

The Case-Shiller report broadly lifted some of the housing sector’s smaller stocks such as Comstock (CHCI, +3.4%), Beazer Homes (BZH, 2.1%), and Hovnanian (HOV, +1.8%), helping the SPDR S&P Homebuilders ETF (XHB) finish roughly 1% ahead.

Tesla Motors (TSLA) reignited an electric 2013 with a 13% gain after announcing that demand for its Model S is strong, expecting to sell more than 500 automobiles total in the coming hear. TSLA shares have more than tripled so far this year. Other American automakers sprung to life, with General Motors (GM) and Ford (F) both ending more than 3% in the black.

On the earnings front, luxury retailer Tiffany & Co. (TIF) gained about 4% after announcing better-than-expected earnings, though it warned of lower future revenues.

In merger news, Valeant Pharmaceuticals (VRX) shares improved 8% after the company announced it will buy privately held Bausch & Lomb from private equity firm Warburg Pincus.

And lastly, AstraZeneca (AZN) announced it will buy specialty pharmaceuticals maker Omthera Pharmaceuticals (OMTH) for $260 million, or $12.70 per share, to roughly double OMTH shareholders’ fortunes. AZN obtained the leading manufacturer of fish-oil based cardiovascular drugs — an area where ASZ is looking to grow beyond its Crestor brand — and also picked up a 2% improvement in its share price.

Three Up

  • Trina Solar (TSL): Up 10.1% (62 cents) to $6.79.
  • Arena Pharmaceutical (ARNA): Up 7.7% (64 cents) to $8.94.
  • Orbitz Worldwide (OWW): Up 6.5% (53 cents) to $8.71.

Three Down

  • Exelon (EXC): Down 7.5% ($2.61) to $32.04.
  • Netflix (NFLX): Down 6.4% ($14.55) to $214.19.
  • Alaska Air (ALK): Down 4.2% ($2.44) to $56.19.

Marc Bastow is an Assistant Editor at As of this writing, he did not hold a position in any of the aforementioned securities.

Article printed from InvestorPlace Media,

©2021 InvestorPlace Media, LLC